	US 12,186,467 B2
	Cleaning of biological fluid
Torbjorn Linden, Hasslo (SE); and Husam Mohammed, Malmo (SE)
Assigned to Gambro Lundia AB, Lund (SE)
Filed by GAMBRO LUNDIA AB, Lund (SE)
Filed on Jan. 13, 2021, as Appl. No. 17/147,615.
Application 17/147,615 is a division of application No. 16/149,443, filed on Oct. 2, 2018, granted, now 10,918,779.
Application 16/149,443 is a division of application No. 14/651,810, granted, now 10,124,107, issued on Nov. 13, 2018, previously published as PCT/EP2013/076574, filed on Dec. 13, 2013.
Claims priority of provisional application 61/737,262, filed on Dec. 14, 2012.
Claims priority of application No. 1251426-1 (SE), filed on Dec. 14, 2012.
Prior Publication US 2021/0128810 A1, May 6, 2021
Int. Cl. A61M 1/34 (2006.01); A61M 1/16 (2006.01); A61M 1/36 (2006.01)

CPC A61M 1/3486 (2014.02) [A61M 1/16 (2013.01); A61M 1/3472 (2013.01); A61M 1/3687 (2013.01); A61M 1/369 (2013.01); A61M 2202/0042 (2013.01); A61M 2202/07 (2013.01); A61M 2205/3368 (2013.01)]

5 Claims

1. A cleaning fluid for removal of deleterious substances from an extracorporeal biological fluid comprising one or more displacer substances selected from C₈-fatty acid, or a salt thereof, salicylic acid, or a salt thereof, or combinations of C₈-fatty acid, or a salt thereof, with salicylic acid, or a salt thereof, and/or with acetylsalicylic acid, or a salt thereof,

wherein the cleaning fluid comprises each of the one or more displacer substances in a concentration ranging from 10 mg/ml to 100 mg/ml, and

wherein the cleaning fluid has pH of between 6.5 and 8.